| Stage | AMGN | % of rev | NBIX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.4B | 100.00% | $1.1B | 100.00% | AMGN ×9.23 |
| Gross profit | $7.6B | 73.10% | $1.1B | 100.00% | NBIX +26.9pp |
| Operating income | $3.7B | 35.79% | $331M | 29.51% | AMGN +6.3pp |
| Pre-tax income | $4.7B | 45.21% | $284M | 25.27% | AMGN +19.9pp |
| Net income | $3.9B | 37.28% | $207M | 18.39% | AMGN +18.9pp |
| Stage | AMGN | NBIX | Gap · A − B |
|---|---|---|---|
| Revenue | $10.4B100.00% | $1.1B100.00% | AMGN ×9.23 |
| Gross profit | 73.10%$7.6B | 100.00%$1.1B | NBIX +26.9pp |
| Operating income | 35.79%$3.7B | 29.51%$331M | AMGN +6.3pp |
| Pre-tax income | 45.21%$4.7B | 25.27%$284M | AMGN +19.9pp |
| Net income |
| 37.28%$3.9B |
| 18.39%$207M |
| AMGN +18.9pp |
No shared counterparties.